Analysts say these ASX growth shares are top buys this month

Travel and data are on the menu with these growth shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're a fan of growth shares, then you may want to read on.

That's because a couple of high-quality shares with lots of growth potential have recently been named as buys.

Here's why analysts are bullish on these growth shares:

a man sits back from his laptop computer with both hands behind his head feeling happy to see the Brambles share price moving significantly higher today

Image source: Getty Images

Corporate Travel Management Ltd (ASX: CTD)

The team at Morgans believes that this corporate travel booker could be an ASX growth share to buy.

The broker feels that Corporate Travel Management is in a strong position after making big changes during the pandemic. This includes reducing its cost base, making two great acquisitions, and building on its technology advantage. It said:

CTD should be a materially larger business post COVID given it has made two highly accretive acquisitions during the downturn. The company has also won a lot of new business, implemented structural cost-out opportunities and continued to develop its market-leading technology.

Morgans has an add rating and a $24 price target on its shares.

NextDC Ltd (ASX: NXT)

Over at Goldman Sachs, its analysts think that NextDC could be an ASX growth share to buy.

NextDC provides colocation services to local and international organisations from its growing portfolio of world-class data centre facilities across Australia. It is also currently in the process of expanding into the Asia-Pacific.

Goldman believes the company is well-placed to deliver growth ahead of the market's expectations thanks to strong demand for data centre capacity. It said:

We reiterate out above consensus expectations for NXT contracted MW wins into FY25/26E, noting our forecast of +28/37MW wins (incl. +9MW in Malaysia/NZ in FY26) is ahead of consensus expectations which imply a period of digestion (+17/23MW) following +37MW announced in FY23TD. This drives our FY25/26E EBITDA +2% vs. Visible Alpha Consensus Data, noting we expect longer dated ramp of contracts going forward (shift from contracted to billing), consistent with recent announcements.

Goldman Sachs has a buy rating and a $14.96 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Nextdc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has recommended Corporate Travel Management. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A golden egg with dividend cash flying out of it
Growth Shares

Forget Easter eggs, these ASX shares could be your best buys this month

These shares could be top buys after the Easter break.

Read more »

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 amazing ASX growth shares I'd buy and hold for the next decade

These shares could be worth holding tightly to for the long term.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Growth Shares

$5,000 invested in Droneshield shares 4 months ago is already worth…

Investors will be thrilled!

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

1 ASX dividend share and 1 ASX growth stock to buy in April

These ASX shares deliver a one-two punch: income now, growth later.

Read more »

Increasing white bar graph with a rising arrow on an orange background.
Growth Shares

Here's what I consider to be the very best ASX 200 share to buy in April

This business looks heavily undervalued to me.

Read more »

Scared people on a rollercoaster holding on for dear life, indicating a plummeting share price
Growth Shares

3 reasons to buy this red-hot ASX healthcare stock today

Brokers think the biotech share is gearing up for its next big move.

Read more »

Multi-ethnic people looking at a camera in a public place and screaming, shouting, and feeling overjoyed.
Growth Shares

2 ASX stocks that could help turn $10,000 into $1 million

I’d think about adding these ASX shares to your portfolio.

Read more »

Part of male mannequin dressed in casual clothes holding a sale paper shopping bag.
Growth Shares

2 ASX financial stocks that could double – or even triple – in value

If sentiment turns and execution delivers, this could be an opportunity investors won’t want to miss.

Read more »